268 related articles for article (PubMed ID: 29288767)
21. Characterization of the diarylether sulfonylester (-)-(R)-3-(2-hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor agonist with neuroprotective properties.
Mauler F; Mittendorf J; Horváth E; De Vry J
J Pharmacol Exp Ther; 2002 Jul; 302(1):359-68. PubMed ID: 12065738
[TBL] [Abstract][Full Text] [Related]
22. Activation of STAT3 is involved in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptors in rats.
Zhou H; Zhang Z; Wei H; Wang F; Guo F; Gao Z; Marsicano G; Wang Q; Xiong L
Brain Res; 2013 Sep; 1529():154-64. PubMed ID: 23880371
[TBL] [Abstract][Full Text] [Related]
23. Activation of cannabinoid receptor 1 is involved in protection against mitochondrial dysfunction and cerebral ischaemic tolerance induced by isoflurane preconditioning.
Cai M; Yang Q; Li G; Sun S; Chen Y; Tian L; Dong H
Br J Anaesth; 2017 Dec; 119(6):1213-1223. PubMed ID: 29045576
[TBL] [Abstract][Full Text] [Related]
24. Diet-Induced Obesity in Cannabinoid-2 Receptor Knockout Mice and Cannabinoid Receptor 1/2 Double-Knockout Mice.
Alshaarawy O; Kurjan E; Truong N; Olson LK
Obesity (Silver Spring); 2019 Mar; 27(3):454-461. PubMed ID: 30699233
[TBL] [Abstract][Full Text] [Related]
25. CB1 and CB2 cannabinoid receptor antagonists prevent minocycline-induced neuroprotection following traumatic brain injury in mice.
Lopez-Rodriguez AB; Siopi E; Finn DP; Marchand-Leroux C; Garcia-Segura LM; Jafarian-Tehrani M; Viveros MP
Cereb Cortex; 2015 Jan; 25(1):35-45. PubMed ID: 23960212
[TBL] [Abstract][Full Text] [Related]
26. Remote Ischemia Preconditioning Attenuates Blood-Spinal Cord Barrier Breakdown in Rats Undergoing Spinal Cord Ischemia Reperfusion Injury: Associated with Activation and Upregulation of CB1 and CB2 Receptors.
Jing N; Fang B; Wang ZL; Ma H
Cell Physiol Biochem; 2017; 43(6):2516-2524. PubMed ID: 29130941
[TBL] [Abstract][Full Text] [Related]
27. Mn-SOD Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation.
Sun S; Chen X; Gao Y; Liu Z; Zhai Q; Xiong L; Cai M; Wang Q
Mol Neurobiol; 2016 Jan; 53(1):331-343. PubMed ID: 25432886
[TBL] [Abstract][Full Text] [Related]
28. Stimulated CB1 Cannabinoid Receptor Inducing Ischemic Tolerance and Protecting Neuron from Cerebral Ischemia.
Zhuang Q; Dai C; Yang L; Wen H; Wang H; Jiang X; Zhang Y
Cent Nerv Syst Agents Med Chem; 2017; 17(2):141-150. PubMed ID: 27142423
[TBL] [Abstract][Full Text] [Related]
29. Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome After Stroke.
Bravo-Ferrer I; Cuartero MI; Zarruk JG; Pradillo JM; Hurtado O; Romera VG; Díaz-Alonso J; García-Segura JM; Guzmán M; Lizasoain I; Galve-Roperh I; Moro MA
Stroke; 2017 Jan; 48(1):204-212. PubMed ID: 27899748
[TBL] [Abstract][Full Text] [Related]
30. Involvement of ERK 1/2 activation in electroacupuncture pretreatment via cannabinoid CB1 receptor in rats.
Du J; Wang Q; Hu B; Peng Z; Zhao Y; Ma L; Xiong L; Lu Y; Zhu X; Chen S
Brain Res; 2010 Nov; 1360():1-7. PubMed ID: 20654595
[TBL] [Abstract][Full Text] [Related]
31. Cerebroprotective effects of TAK-937, a cannabinoid receptor agonist, on ischemic brain damage in middle cerebral artery occluded rats and non-human primates.
Suzuki N; Suzuki M; Murakami K; Hamajo K; Tsukamoto T; Shimojo M
Brain Res; 2012 Jan; 1430():93-100. PubMed ID: 22119394
[TBL] [Abstract][Full Text] [Related]
32. Cannabinoid receptor subtype 2 (CB2R) agonist, GW405833 reduces agonist-induced Ca(2+) oscillations in mouse pancreatic acinar cells.
Huang Z; Wang H; Wang J; Zhao M; Sun N; Sun F; Shen J; Zhang H; Xia K; Chen D; Gao M; Hammer RP; Liu Q; Xi Z; Fan X; Wu J
Sci Rep; 2016 Jul; 6():29757. PubMed ID: 27432473
[TBL] [Abstract][Full Text] [Related]
33. Evidence for CB2 receptor involvement in LPS-induced reduction of cAMP intracellular levels in uterine explants from pregnant mice: pathophysiological implications.
Salazar AI; Carozzo A; Correa F; Davio C; Franchi AM
Mol Hum Reprod; 2017 Jul; 23(7):500-508. PubMed ID: 28460003
[TBL] [Abstract][Full Text] [Related]
34. CB2 receptor activation attenuates microcirculatory dysfunction during cerebral ischemic/reperfusion injury.
Zhang M; Adler MW; Abood ME; Ganea D; Jallo J; Tuma RF
Microvasc Res; 2009 Jun; 78(1):86-94. PubMed ID: 19332079
[TBL] [Abstract][Full Text] [Related]
35. Early T1- and T2-weighted MRI signatures of transient and permanent middle cerebral artery occlusion in a murine stroke model studied at 9.4T.
Barber PA; Hoyte L; Kirk D; Foniok T; Buchan A; Tuor U
Neurosci Lett; 2005 Nov; 388(1):54-9. PubMed ID: 16055267
[TBL] [Abstract][Full Text] [Related]
36. Genetic deletion of the cannabinoid receptors CB1 and CB2 enhances inflammation with diverging effects on skin wound healing in mice.
Ruhl T; Lippold EF; Christer T; Schaefer B; Kim BS; Beier JP
Life Sci; 2021 Nov; 285():120018. PubMed ID: 34624321
[TBL] [Abstract][Full Text] [Related]
37. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain.
Onaivi ES; Ishiguro H; Gong JP; Patel S; Perchuk A; Meozzi PA; Myers L; Mora Z; Tagliaferro P; Gardner E; Brusco A; Akinshola BE; Liu QR; Hope B; Iwasaki S; Arinami T; Teasenfitz L; Uhl GR
Ann N Y Acad Sci; 2006 Aug; 1074():514-36. PubMed ID: 17105950
[TBL] [Abstract][Full Text] [Related]
38. Role of CB1 and CB2 cannabinoid receptors in the development of joint pain induced by monosodium iodoacetate.
La Porta C; Bura SA; Aracil-Fernández A; Manzanares J; Maldonado R
Pain; 2013 Jan; 154(1):160-174. PubMed ID: 23199705
[TBL] [Abstract][Full Text] [Related]
39. Cannabinoid receptor type 1 agonist ACEA improves motor recovery and protects neurons in ischemic stroke in mice.
Caltana L; Saez TM; Aronne MP; Brusco A
J Neurochem; 2015 Nov; 135(3):616-29. PubMed ID: 26296704
[TBL] [Abstract][Full Text] [Related]
40. Genetic or pharmacological depletion of cannabinoid CB1 receptor protects against dopaminergic neurotoxicity induced by methamphetamine in mice.
Dang DK; Shin EJ; Mai AT; Jang CG; Nah SY; Jeong JH; Ledent C; Yamamoto T; Nabeshima T; Onaivi ES; Kim HC
Free Radic Biol Med; 2017 Jul; 108():204-224. PubMed ID: 28363605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
